Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-ForMyl-3-Methylbenzoic acid, also known as 4-Formyl-3-methylbenzoate, is an organic compound with the molecular formula C8H6O3. It is a derivative of benzoic acid, featuring a formyl group (C=O) at the 4th position and a methyl group (-CH3) at the 3rd position. 4-ForMyl-3-Methylbenzoic acid is characterized by its aromatic structure and functional groups, which contribute to its chemical reactivity and potential applications in various fields.

24078-23-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 24078-23-7 Structure
  • Basic information

    1. Product Name: 4-ForMyl-3-Methylbenzoic acid
    2. Synonyms: 4-ForMyl-3-Methylbenzoic acid
    3. CAS NO:24078-23-7
    4. Molecular Formula: C9H8O3
    5. Molecular Weight: 164.15802
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 24078-23-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 340.5±30.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.263±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 3.85±0.10(Predicted)
    10. CAS DataBase Reference: 4-ForMyl-3-Methylbenzoic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-ForMyl-3-Methylbenzoic acid(24078-23-7)
    12. EPA Substance Registry System: 4-ForMyl-3-Methylbenzoic acid(24078-23-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 24078-23-7(Hazardous Substances Data)

24078-23-7 Usage

Uses

Used in Pharmaceutical Industry:
4-ForMyl-3-Methylbenzoic acid is used as a key intermediate in the synthesis of novel alkylaminomethyl substituted phenyl and thienyl derivatives. These derivatives have been identified as potent S1PR1 agonists, which are important in the development of drugs targeting various diseases, including multiple sclerosis, autoimmune disorders, and certain types of cancer. The compound's unique structure allows for the creation of new molecules with potential therapeutic properties, making it a valuable asset in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 24078-23-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,0,7 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 24078-23:
(7*2)+(6*4)+(5*0)+(4*7)+(3*8)+(2*2)+(1*3)=97
97 % 10 = 7
So 24078-23-7 is a valid CAS Registry Number.

24078-23-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-formyl-3-methyl benzoic acid

1.2 Other means of identification

Product number -
Other names 4-formyl-3-methylbenzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24078-23-7 SDS

24078-23-7Downstream Products

24078-23-7Relevant articles and documents

Novel S1P1 receptor agonists - Part 4: Alkylaminomethyl substituted aryl head groups

Lescop, Cyrille,Müller, Claus,Mathys, Boris,Birker, Magdalena,De Kanter, Ruben,Kohl, Christopher,Hess, Patrick,Nayler, Oliver,Rey, Markus,Sieber, Patrick,Steiner, Beat,Weller, Thomas,Bolli, Martin H.

, p. 222 - 238 (2016/04/20)

In a previous communication we reported on the discovery of alkylamino pyridine derivatives (e.g. 1) as a new class of potent, selective and efficacious S1P1 receptor (S1PR1) agonists. However, more detailed profiling revealed that this compound class is phototoxic in vitro. Here we describe a new class of potent S1PR1 agonists wherein the exocyclic nitrogen was moved away from the pyridine ring (e.g. 11c). Further structural modifications led to the identification of novel alkylaminomethyl substituted phenyl and thienyl derivatives as potent S1PR1 agonists. These new alkylaminomethyl aryl compounds showed no phototoxic potential. Based on their in vivo efficacy and ability to penetrate the brain, the 5-alkyl-aminomethyl thiophenes appeared to be the most interesting class. Potent and selective S1PR1 agonist 20e, for instance, maximally reduced the blood lymphocyte count (LC) for 24 h after oral administration of 10 mg/kg to rat and its brain concentrations reached >500 ng/g over 24 h.

IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF

-

Paragraph 206, (2014/08/19)

This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.

SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS

-

Page/Page column 48, (2013/10/22)

The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.

NOVEL AMINOMETHYL BENZENE DERIVATIVES

-

, (2009/10/22)

The invention relates to novel aminomethyl benzene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. (I) wherein A represents one of the groups (I), (I), (I) and

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 24078-23-7